Kris Ver Donck

Kris Ver Donck joined Nucomat in 2025 as as Director Creative Solutions. He holds an MSc in biochemistry from the University of Antwerp and has experience in developing and commercialising scientific technology from a range of organizations across Europe, including Johnson & Johnson, Trinean, the University of Luxembourg, FOx Biosystems and Nucomat. Some of his achievements include leading the development of a high-throughput image analysis platform, concept and implementation a robotic biosafety screening lab for viruses and high risk pathogens, assay development and high throughput screening, supporting drug development from lab to clinical trials, rebuilding sales channels, develop and implement go-to-market plans for novel technologies.